NCT02858817View on ClinicalTrials.gov

Safety and Protective Efficacy of IV Immunization With Cryopreserved PfSPZ Under A/P Chemoprophylaxis

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 28, 2016

Primary Completion Date

November 16, 2017

Study Completion Date

November 16, 2017

Conditions
Malaria
Interventions
DRUG

atovaquone/proguanil 250mg/100mg (A/P)

Combination drug for chemo-prophylaxis or treatment of malaria

BIOLOGICAL

PfSPZ Challenge (NF54)

cryo-preserved Plasmodium falciparum sporozoites injected by venous inoculation

OTHER

NaCl 0,9%

0.9% NaCl solution for injection

All Listed Sponsors
collaborator

Sanaria Inc.

INDUSTRY

lead

University Hospital Tuebingen

OTHER

NCT02858817 - Safety and Protective Efficacy of IV Immunization With Cryopreserved PfSPZ Under A/P Chemoprophylaxis | Biotech Hunter | Biotech Hunter